Back to search

France· FR:62907143

PRIMAQUINE SANOFI 15 mg, comprimé pelliculé

A primaquine product containing phosphate de primaquine, registered in France by SANOFI WINTHROP INDUSTRIE. The same ATC class is registered in 7 of our 19 countries.

ATC P01BA03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPRIMAQUINE SANOFI 15 mg, comprimé pel…ATCP01BA03REGISTER NO.FR:62907143PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Primaquine is registered in 7 of 19 countries.

Countries holding a registration under ATC P01BA03 (primaquine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 4 of them publish a price we can compare per daily dose

Primaquine · ATC P01BA03

7 / 19 countries

  • Canada
  • Czechiaprice
  • Franceprice
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PHOSPHATE DE PRIMAQUINE
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
P01BA03
ATC class
Primaquine
Defined daily dose
15 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400930293225
    1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 14 comprimés reconditionnés
  • cip13
    3400955101369
    1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 100 comprimés avec kit de reconditionnement

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

348 interactions on record for primaquine.

Graded by severity as the source publishes them — 88 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Primaquine · interactions on record

348 records

  • 88 severe
  • 255 moderate
  • 5 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Primaquine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All primaquine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Cyprus · Primaquine Remedica

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c57747f8-d786-4a3e-b8f8-cd69c02abdb8
GET /v1/drugs/c57747f8-d786-4a3e-b8f8-cd69c02abdb8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62907143",
  "date_amm": "2024-05-27",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "PHOSPHATE DE PRIMAQUINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about primaquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.